Impella Device
The Impella device is a miniaturized ventricular assist device that provides
temporary mechanical circulatory support.
While observational data suggests potential benefits in reducing mortality for cardiogenic shock, randomized controlled trial data is still lacking to definitively prove its efficacy. Complications can include bleeding, vascular injury, and infection. Overall, the Impella offers a less invasive option for temporary circulatory support in critically ill cardiac patients
Who Needs ?
- Patients with cardiogenic shock, especially following acute myocardial infarction
- High-risk percutaneous coronary intervention (PCI) cases
- Acute decompensated heart failure
- Patients awaiting heart transplant
- Support during ventricular tachycardia ablation
- Bridge to left ventricular assist device (LVAD) implantation
- Post cardiotomy shock
- Off-pump coronary bypass surgery


Symptoms it can help with
- Shortness of breath
- Fatigue
- Chest pain
- Dizziness or fainting
- Symptoms of cardiogenic shock
Advantages post-procedure
- Improves cardiac output and organ perfusion
- Reduces workload on the heart, allowing it to rest and recover
- Maintains blood flow during high-risk procedures
- Can improve survival rates in cardiogenic shock
- Allows time for cardiac recovery or bridge to further treatment
- Less invasive than surgical ventricular assist devices
Key features
- Inserted percutaneously via the femoral artery
- Pumps blood from the left ventricle into the ascending aorta
- Can provide 2.5-5.0 L/min of blood flow support
- Allows for immediate and sustained left ventricular unloadin
- Available in different sizes/models for various clinical needs